Compare Novavax Inc (NVAX) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Warner Music Group Corp — how do they compare? Novavax Inc trades at $12.74 (market cap $1.82B), while Warner Music Group Corp trades at $28.76 (market cap $15.12B). The key difference: Warner Music Group Corp is far larger — about 8.3× Novavax Inc's market cap, and Warner Music Group Corp pays a 2.77% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and Warner Music Group Corp for 96 Days on average.
| NVAX | WMG | |
|---|---|---|
Market Cap | $1.82B | $15.12B |
Volume | 6,198,505 | 2,966,414 |
Sector | Health | Media |
52-Week High | $12.56 | $34.72 |
52-Week Low | $6.22 | $23.65 |
Typical Hold Time | 59 Days | 96 Days |
Enterprise Value | $1.39B | $19.42B |
Dividend Yield | — | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $12.75, up 13.64% with strong technical momentum and bullish moving averages. The company shows mixed fundamentals with revenue of $1.12B in 2025 and positive net income of $440.30M, though 2026 projections indicate a return to losses. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivot toward Matrix-M adjuvant licensing partnerships.
The outlook remains speculative with high volatility. Opportunities include partnership-driven growth and vaccine demand, but risks involve consistent profitability challenges, high debt-to-asset ratios, and competitive pressures. Analyst sentiment is predominantly bullish (73.9% buy ratings), yet investors should weigh the company's transition phase against financial stability concerns.
Warner Music Group (WMG) trades at $28.72, up 1.99% today, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates, and maintains a robust gross profit margin of 45.77%. Recent news highlights strategic AI partnerships and licensing renewals, signaling growth initiatives. Revenue has grown from $5.9B in 2022 to $6.7B in 2025, with a projected increase to $7.3B in 2026.
The outlook for WMG is positive, driven by earnings beats, analyst optimism, and AI-driven content curation opportunities. Key risks include competitive pressures in the music industry and execution challenges amid leadership changes. The consensus price target of $39.50 implies significant upside, but investors should monitor margin trends and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
